W. Brown

发表

3-Hydroxyacyl-CoA and Alcohol Dehydrogenase Activities of Mitochondrial Type 10 17β-Hydroxysteroid Dehydrogenase in Neurodegeneration Study

Song-Yu Yang, C. Dobkin, Xue‐Ying He, 2022, Journal of Alzheimer's disease : JAD.

Brain region‐specific deficit in mitochondrial electron transport chain complexes in children with autism

J. Wegiel, M. Essa, K. Kaur, 2011, Journal of neurochemistry.

Stereological study of the neuronal number and volume of 38 brain subdivisions of subjects diagnosed with autism reveals significant alterations restricted to the striatum, amygdala and cerebellum

J. Wegiel, W. Brown, T. Wisniewski, 2014, Acta Neuropathologica Communications.

Is Taurine a Biomarker in Autistic Spectrum Disorder?

W. Brown, I. Cohen, E. Park, 2017, Advances in experimental medicine and biology.

Reply to Duncan: Fragile X leads to X chromosome loss: Comments from a cytogeneticist

S. Nolin, C. Dobkin, W. Brown, 2010 .

Infantile Neurodegeneration results from Mutants of 17β‐Hydroxysteroid Dehydrogenase Type 10 rather than Aβ‐Binding Alcohol Dehydrogenase

Song-Yu Yang, C. Dobkin, Xue‐Ying He, 2022, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Contributions of phonological and verbal working memory to language development in adolescents with fragile X syndrome

W. Brown, E. I. Pierpont, L. Abbeduto, 2011, Journal of Neurodevelopmental Disorders.

Molecular Analysis of Fragile X Syndrome

S. Nolin, C. Dobkin, W. Brown, 2003, Current protocols in human genetics.

Fragile X full mutation alleles composed of few alleles: Implications for CGG repeat expansion

S. Nolin, G. Houck, C. Dobkin, 2008, American journal of medical genetics. Part A.

Oxidative stress in autism: increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferrin--the antioxidant proteins.

W. Brown, I. Cohen, A. Chauhan, 2004, Life sciences.

A two-dimensional protein fragmentation-proteomic study of neuronal ceroid lipofuscinoses: identification and characterization of differentially expressed proteins.

W. Brown, Bing He, E. Jenkins, 2011, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Mosaicism for the FMR1 gene influences adaptive skills development in fragile X-affected males.

W. Brown, I. Cohen, S. Nolin, 1996, American journal of medical genetics.

Mosaicism in fragile X affected males.

W. Brown, S. Nolin, G. Houck, 1994, American journal of medical genetics.

IL-6 is increased in the cerebellum of autistic brain and alters neural cell adhesion, migration and synaptic formation

A. Sheikh, W. Brown, M. Malik, 2011, Journal of Neuroinflammation.

KH domain-containing proteins of yeast: absence of a fragile X gene homologue.

W. Brown, J. Currie, W. Brown, 1999, American journal of medical genetics.

Clinicopathological Stratification of Idiopathic Autism and Autism with 15q11.2–q13 Duplications

E. Cook, J. Wegiel, W. Brown, 2013 .

Neuropsychiatric Symptoms of Fragile X Syndrome

W. Brown, J. Tsiouris, W. Brown, 2004, CNS drugs.

Increasing Maternal or Post-Weaning Folic Acid Alters Gene Expression and Moderately Changes Behavior in the Offspring

W. Brown, Subit Barua, U. Begum, 2014, PloS one.

Decreased GABAA receptor expression in the seizure-prone fragile X mouse

W. Brown, C. Dobkin, A. El Idrissi, 2005, Neuroscience Letters.

Taurine improves congestive functions in a mouse model of fragile X syndrome.

W. Brown, A. El Idrissi, W. Brown, 2009, Advances in experimental medicine and biology.

A comparison of adult and childhood progerias: Werner syndrome and Hutchinson-Gilford progeria syndrome.

R. Dutkowski, E. Jenkins, G. Houck, 1985, Advances in experimental medicine and biology.

Molecular Quantitation of Aneuploid Conditions Using Chromosome 21 as a Model

A. Eisenberg, I. Balazs, G. Houck, 1985, Annals of the New York Academy of Sciences.

Late infantile neuronal ceroid lipofuscinosis is due to splicing mutations in the CLN2 gene.

W. Brown, J. Hartikainen, K. Wisniewski, 1999, Molecular genetics and metabolism.

Rapid fragile X carrier screening and prenatal diagnosis using a nonradioactive PCR test.

W. Brown, A. Jeziorowska, S. Brooks, 1994, JAMA.

RNAs that interact with the fragile X syndrome RNA binding protein FMRP.

W. Brown, R. Denman, Y. Sung, 2000, Biochemical and biophysical research communications.

Response to nutritional and growth hormone treatment in progeria.

W. Brown, J. Abdenur, F. Lifshitz, 1997, Metabolism: clinical and experimental.

Prevalence of Psychotropic Drug Use in Adults with Intellectual Disability: Positive and Negative Findings from a Large Scale Study

W. Brown, I. Cohen, Soh-Yule Kim, 2013, Journal of autism and developmental disorders.